In the original article Accolla et al. (1985, 1986) were not cited in the article. In addition, we erroneously stated the years in which CIITA was discovered; it should have been 1985–1986. The citation and correct date have been inserted in introduction, second paragraph.
The corrected paragraph should read:
In mammals, NLRs are able to recognize bacterial flagella, lipopolysaccharide, RNA, and muramyl dipeptides in the cytoplasm (Franchi et al., 2009). NLRs can be divided into five subfamilies according to the difference in the N-terminal effector domain (Ting and Davis, 2005). Class II major histocompatibility complex (MHC-II) transactivator (CIITA), discovered in 1985–1986 (Accolla et al., 1985, 1986), and contains an acidic transcriptional activation motif in the N-terminal domain, so it belongs to the NLRA subfamily. CIITA plays an important role in the MHC-II transcriptional activation and is positively correlated with the MHC-II transcription level (Muhlethaler-Mottet et al., 1997; Zuo and Rowe, 2012). In addition, CIITA can regulate the presentation function of antigen presentation cells by controlling the transcription level of MHC-II (van den Elsen et al., 2004; Lupfer and Kanneganti, 2012). However, CIITA does not directly bind to DNA but rather acts as a transcriptional co-activator through the activation of transcription factors (Sisk et al., 2003). In addition, CIITA can trans-activate the expression of MHC-II in antigen presentation cells and virus-infected target cells, inducing host-derived antiviral responses, thereby inhibiting the viral replication in the host and eliminating virus infection (Tosi et al., 2011).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.
Statements
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AccollaR. S.JotterandbellomoM.ScarpellinoL.MaffeiA.CarraG.GuardiolaJ. (1986). aIr-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression. J. Exp. Med.164, 369–374.
2
AccollaR. S.ScarpellinoL.CarraG.GuardiolaJ. (1985). Trans-acting element(s) operating across species barriers positively regulate expression of major histocompatibility complex class II genes. J. Exp. Med.162:1117.
3
FranchiL.WarnerN.VianiK.NuñezG. (2009). Function of Nod-like receptors in microbial recognition and host defense. Immunol. Rev.227, 106–128. 10.1111/j.1600-065X.2008.00734.x
4
LupferC. R.KannegantiT.-D. (2012). The role of inflammasome modulation in virulence. Virulence3, 262–270. 10.4161/viru.20266
5
Muhlethaler-MottetA.OttenL. A.SteimleV.MachB. (1997). Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J.16, 2851–2860. 10.1093/emboj/16.10.2851
6
SiskT. J.NickersonK.KwokR. P.ChangC. H. (2003). Phosphorylation of class II transactivator regulates its interaction ability and transactivation function. Int. Immunol.15, 1195–1205. 10.1093/intimm/dxg116
7
TingJ. P.DavisB. K. (2005). CATERPILLER: a novel gene family important in immunity, cell death, and diseases. Annu. Rev. Immunol.23, 387–414. 10.1146/annurev.immunol.23.021704.115616
8
TosiG.ForlaniG.AndresenV.TurciM.BertazzoniU.FranchiniG.et al. (2011). Major histocompatibility complex class II transactivator CIITA is a viral restriction factor that targets human T-cell lymphotropic virus type 1 Tax-1 function and inhibits viral replication. J. Virol.85, 10719–10729. 10.1128/JVI.00813-11
9
van den ElsenP. J.HollingT. M.KuipersH. F.Van Der StoepN. (2004). Transcriptional regulation of antigen presentation. Curr. Opin. Immunol.16, 67–75. 10.1016/j.coi.2003.11.015
10
ZuoJ.RoweM. (2012). Herpesviruses placating the unwilling host: manipulation of the MHC class II antigen presentation pathway. Viruses4, 1335–1353. 10.3390/v4081335
Summary
Keywords
Cherry Valley duck, CIITA, sequence analysis, receptor expression, inflammatory cytokines, antibacterial ability, innate immunity
Citation
Li R, Guo M, Lin J, Chai T and Wei L (2017) Corrigendum: Molecular Cloning, Characterization, and Anti-avian Pathogenic Escherichia coli Innate Immune Response of the Cherry Valley Duck CIITA Gene. Front. Microbiol. 8:2172. doi: 10.3389/fmicb.2017.02172
Received
15 September 2017
Accepted
23 October 2017
Published
31 October 2017
Volume
8 - 2017
Edited and reviewed by
Juarez Antonio Simões Quaresma, Universidade Federal do Pará, Brazil
Updates
Copyright
© 2017 Li, Guo, Lin, Chai and Wei.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Tongjie Chai chaitj117@163.com
This article was submitted to Microbial Immunology, a section of the journal Frontiers in Microbiology
†These authors have contributed equally to this work.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.